UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
82.00 -0.63 (-0.76%) GOLD FUTURES
2,306.50 -51.20 (-2.17%) DOW
38,002.87 -383.22 (-1.00%) Bitcoin GBP
50,119.69 -539.11 (-1.06%)
BNTX Sep 2024 125.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 0.4800 |
| Open | 0.4800 |
| Bid | 0.4500 |
| Ask | 0.6500 |
| Strike | 125.00 |
| Expiry date | 2024-09-20 |
| Day's range | 0.4800 - 0.4800 |
| Contract range | N/A |
| Volume | |
| Open interest | 21 |
ZacksBioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
On BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its pipeline development now that the pandemic is over.
The TelegraphWall Street plunges after US inflation shock
US stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
- Reuters
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic.
© 2024 Yahoo. All rights reserved.